BONUCCELLI, UBALDO
 Distribuzione geografica
Continente #
NA - Nord America 28.222
EU - Europa 11.304
AS - Asia 3.785
AF - Africa 427
OC - Oceania 65
SA - Sud America 31
Continente sconosciuto - Info sul continente non disponibili 11
Totale 43.845
Nazione #
US - Stati Uniti d'America 27.485
IT - Italia 4.578
CN - Cina 1.932
SE - Svezia 1.927
BG - Bulgaria 1.196
DE - Germania 967
CA - Canada 729
SG - Singapore 591
GB - Regno Unito 560
UA - Ucraina 541
VN - Vietnam 478
FI - Finlandia 450
TR - Turchia 385
AT - Austria 274
CH - Svizzera 231
CI - Costa d'Avorio 204
RU - Federazione Russa 167
HK - Hong Kong 145
IN - India 139
NG - Nigeria 139
FR - Francia 138
SN - Senegal 73
BE - Belgio 65
PL - Polonia 49
AU - Australia 48
NL - Olanda 38
KR - Corea 28
CZ - Repubblica Ceca 26
BR - Brasile 17
NZ - Nuova Zelanda 17
TW - Taiwan 17
IE - Irlanda 16
ES - Italia 15
GR - Grecia 15
JP - Giappone 14
IL - Israele 12
IR - Iran 11
EU - Europa 10
ID - Indonesia 10
RO - Romania 10
HU - Ungheria 8
DK - Danimarca 7
CO - Colombia 6
HR - Croazia 6
MX - Messico 6
EE - Estonia 5
PE - Perù 5
ZA - Sudafrica 5
PT - Portogallo 4
BN - Brunei Darussalam 3
MY - Malesia 3
NO - Norvegia 3
AR - Argentina 2
BA - Bosnia-Erzegovina 2
EG - Egitto 2
IQ - Iraq 2
PH - Filippine 2
SA - Arabia Saudita 2
TH - Thailandia 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
CU - Cuba 1
DZ - Algeria 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
SC - Seychelles 1
TN - Tunisia 1
TZ - Tanzania 1
UZ - Uzbekistan 1
Totale 43.845
Città #
Woodbridge 4.157
Fairfield 3.479
Ann Arbor 2.739
Houston 2.583
Chandler 2.019
Ashburn 1.775
Seattle 1.463
Serra 1.294
Cambridge 1.232
Sofia 1.193
Wilmington 1.180
Milan 984
Jacksonville 779
New York 724
Beijing 720
Ottawa 685
Princeton 527
Lawrence 463
Medford 438
Izmir 370
Nanjing 354
Des Moines 313
Vienna 261
Dearborn 242
Singapore 227
Florence 220
Bern 213
Abidjan 204
Dong Ket 192
Pisa 168
Nanchang 156
San Diego 149
Jüchen 145
Redwood City 140
Lagos 139
Frankfurt am Main 135
Lancaster 128
Hong Kong 123
Rome 106
Kunming 96
Bremen 90
London 88
Norwalk 83
Ogden 75
Shenyang 75
Dakar 73
Boulder 63
Pune 63
Hebei 62
Brussels 56
Changsha 55
Tianjin 47
Guangzhou 44
Jiaxing 44
Hefei 42
Los Angeles 42
Washington 37
Boardman 35
Warsaw 31
Hangzhou 26
Auburn Hills 25
Düsseldorf 23
Nürnberg 22
Phoenix 22
Vicopisano 22
Shanghai 21
Verona 21
Jinan 20
Orange 20
Trieste 20
Livorno 19
Chicago 18
Detroit 18
Kent 18
Torino 17
Dallas 15
Falls Church 14
Lucca 14
Massa 14
Melbourne 14
Radomsko 14
Auckland 13
Cascina 13
Central District 12
Changchun 12
San Francisco 12
Fuzhou 11
Tappahannock 11
Bergamo 10
Bologna 10
Chengdu 10
Council Bluffs 10
Indiana 10
Kostroma 10
Munich 10
Paris 10
Seodaemun-gu 10
Simi Valley 10
Brno 9
Genova 9
Totale 34.239
Nome #
Il fenomeno dell'abitudine del riflesso trigemino-faciale: confronto tra malattia di Parkinson e atrofia multisistemica. 375
Actigraphic sleep detection: an artificial intelligence approach 289
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 242
Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease 215
Occurrence of seizures and EEG interictal epileptiform discharges in AD patients and their correlation with clinical features: a cross-sectional study 185
Novel MTCYB mutation in a young patient with recurrent stroke-like episodes and status epilepticus. 177
Descrizione di un caso di Neuromiotonia associata a tetania normocalcemica 176
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects 176
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 173
Epilepsy occurrence in patients with Alzheimer's disease: clinical experience in a tertiary dementia center 166
A case of pelvic floor myoclonic jerk syndrome. 160
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease 159
Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer's Disease. 159
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseases 157
Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily 152
Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study 148
Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease 148
Mapping Cortical Degeneration in ALS with Magnetization Transfer Ratio and Voxel-Based Morphometry 147
Intra-arterial tissue plasminogen activator and abciximab in patients with acute basilar artery occlusion 147
Acute and chronic effects of clozapine in essential tremor 146
Chronic Migraine with Medication Overuse and OnabotulinumtoxinA: Two Positive Case Reports of a Modified Injection Protocol 146
Activity-based diary for Parkinson's disease, 145
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 145
Oxidative stress in cerebral small vessel disease dizziness patients, basally and after polyphenol compound supplementation 145
Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients 145
A whole-brain analysis in de novo Parkinson disease 144
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment. 144
Endothelium and oxidative stress: The Pandora's Box of cerebral (and non-only) small vessel disease? 144
Sleep Disorders in an elderly population and their relationship with cognitive symptoms: an epidemiological survey 144
The Neuroanatomy of the Reticular Nucleus Locus Coeruleus in Alzheimer's Disease. 143
α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise 143
Mitochondrial DNA haplogroups may influence Fabry disease phenotype 142
Cyclic alternating pattern and interictal epileptiform discharges during morning sleep after sleep deprivation in temporal lobe epilepsy 142
DISRUPTION OF SLEEP-WAKE CONTINUUM IN MYOTONIC DYSTROPHY TYPE I: SLEEP MACROSTRUCTURAL AND MICROSTRUCTURAL FINDINGS 141
Cerebellar ataxia with complete clinical recovery and resolution of MRI lesions related to central pontine myelinolysis: case report and literature review 139
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction 139
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia 138
Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study 138
The precuneus-a witness for excessive aβ gathering in alzheimer's disease pathology 138
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 137
Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation. 137
Role of dopamine agonists in Parkinson's disease: an update 136
A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapy. 135
A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis 135
Relation between plasmatic and cerebrospinal fluid oxidative stress biomarkers and intrathecal ig synthesis in multiple sclerosis patients 135
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 135
Reduced luteinizing hormone secretion in women with Parkinson's disease 134
Spectrum of addictions in Parkinson's disease: from dopamine dysregulation syndrome to impulse control disorders 134
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients 133
Effect of metadoxine on striatal dopamine levels in C57 black mice 133
Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany 133
IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study 132
Perioperative atrial fibrillation and the long-term risk of ischemic stroke 132
Dopamine agonists in the treatment of Parkinson's disease 130
Thyroid function and oral TRH in amyotrophic lateral sclerosis 129
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial 128
Prefrontal cortex, dopamine, and jealousy endophenotype. 128
SUNA syndrome with seasonal pattern 128
Caudate dopaminergic denervation and visual hallucinations: Evidence from a 123I-FP-CIT SPECT study 128
Nummular headache dramatically responsive to indomethacin 127
SSRIs do not worsen Parkinson's disease: Evidence from an open-label, prospective study 127
Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes 127
Identification and determination of 3,4-dihydroxyphenylacetaldehyde, the dopamine metabolite in in vivo dialysate from rat striatum. 127
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 127
A pilot trial of deferiprone for neurodegeneration with brain iron accumulation 126
Postpartum headache due to spontaneous cervical artery dissection 126
Acute encephalopathy of the temporal lobes leading to m.3243A>G. When MELAS is not always MELAS 125
null 125
Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study. 124
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease 123
Iowa gambling task in Parkinson's disease 123
A case of sarcoidosis presenting as a non-specific intramedullary lesion 123
Evidences of Reduced Antioxidant Activity in Patients with Chronic Migraine and Medication-Overuse Headache 123
Aerobic rehabilitation program for improving muscle function in Parkinson's disease 123
Clinical pharmacokinetics of cabergoline 122
Levodopa in the treatment of Parkinson's disease: current controversies 122
Iowa Gambling Task in de novo Parkinson's disease: a comparison between good and poor performers 122
Event-based prospective memory in newly diagnosed, drug-naive Parkinson's disease patients 122
Efficacy of a combined therapeutic approach in the management of Pisa Syndrome 121
null 121
Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats 120
Decision making in de novo Parkinson's disease 120
Cerebral sinus venous thrombosis: Clinical and pathogenetic perspectives from Tuscany 120
Association Between CSF Beta-Amyloid and Apathy in Early-Stage Alzheimer Disease 120
Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists 119
Species differences in the role of excitatory amino acids in experimental parkinsonism. 119
Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test 119
Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study 119
The association between motor subtypes and alexithymia in de novo Parkinson's disease. 118
Preferential occurrence of attacks during night sleep and/or upon awakening negatively affects migraine clinical presentation 118
Association of cerebrospinal fluid α-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers 118
Clinical and pharmacokinetic evaluation of L-dopa and cabergoline cotreatment in Parkinson's disease, 117
Imaging in Glucocerebrosidase-Associated Parkinsonism: Current Status and Implications for Pathophysiology. 117
null 117
Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1 117
Myopathic involvement in two cases of Hallervorden-Spatz disease 116
Depressive symptoms in Parkinson's disease 116
COMPARISON OF THE EFFECTS OF BARBEXACLONE AND PHENOBARBITAL ON EPILEPTIC PATIENTS 115
Observational study of sleep-related disorders in Italian patients with Parkinson's disease: usefulness of the Italian version of Parkinson's disease sleep scale 115
Epidemiology and cerebrovascular events related to cervical and intracranial arteries dissection: the experience of the city of Pisa 115
Totale 14.015
Categoria #
all - tutte 106.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209.845 1.105 675 1.158 608 924 1.086 1.129 787 993 542 651 187
2020/20214.127 363 268 273 195 528 249 301 366 377 357 244 606
2021/20224.933 85 206 101 328 995 674 97 273 339 142 263 1.430
2022/20236.216 758 751 419 522 824 834 56 466 1.018 35 441 92
2023/20244.670 642 507 569 281 627 891 184 185 80 83 199 422
2024/202519 19 0 0 0 0 0 0 0 0 0 0 0
Totale 44.576